Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E DAVIS

Showing results (561-570 of 597) with videos related to

Pageof 60
Sort By:
Antimicrobial Agents and Chemotherapy|May 13, 2015
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean womenJohn M Benjamin, Brioni R Moore, Sam Salman, et al.
Diabetes Care|January 3, 2012
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD StudyRu-Dee Ting, Anthony C Keech, Paul L Drury, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination TherapyStephan Karl, Moses Laman, Brioni R Moore, et al.
Journal of Clinical Medicine|July 2, 2021
Cognitive Impairment in People with Diabetes-Related Foot UlcerationRanita Siru, Melanie S Burkhardt, Wendy A Davis, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Pharmacokinetic properties of azithromycin in pregnancySam Salman, Stephen J Rogerson, Kay Kose, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 11, 2023
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatmentSze-Ann Woon, Brioni R Moore, Moses Laman, et al.
Malaria Journal|July 9, 2013
Prognostic indicators in adults hospitalized with falciparum malaria in Western ThailandPaul N Newton, Kasia Stepniewska, Arjen Dondorp, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2023
Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in childrenBrioni R Moore, Sam Salman, Roselyn Tobe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferasesKenneth F Ilett, Brian T Ethell, James L Maggs, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malariaS G Zaloumis, J Tarning, S Krishna, et al.
Pageof 60

Showing results (561-570 of 597) with videos related to

Sort By:
Pageof 60
Antimicrobial Agents and Chemotherapy|May 13, 2015
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean womenJohn M Benjamin, Brioni R Moore, Sam Salman, et al.
Diabetes Care|January 3, 2012
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD StudyRu-Dee Ting, Anthony C Keech, Paul L Drury, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination TherapyStephan Karl, Moses Laman, Brioni R Moore, et al.
Journal of Clinical Medicine|July 2, 2021
Cognitive Impairment in People with Diabetes-Related Foot UlcerationRanita Siru, Melanie S Burkhardt, Wendy A Davis, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Pharmacokinetic properties of azithromycin in pregnancySam Salman, Stephen J Rogerson, Kay Kose, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 11, 2023
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatmentSze-Ann Woon, Brioni R Moore, Moses Laman, et al.
Malaria Journal|July 9, 2013
Prognostic indicators in adults hospitalized with falciparum malaria in Western ThailandPaul N Newton, Kasia Stepniewska, Arjen Dondorp, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 3, 2023
Short-course, high-dose primaquine regimens for the treatment of liver-stage vivax malaria in childrenBrioni R Moore, Sam Salman, Roselyn Tobe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferasesKenneth F Ilett, Brian T Ethell, James L Maggs, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 6, 2014
Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malariaS G Zaloumis, J Tarning, S Krishna, et al.
Pageof 60